Literature DB >> 10595359

Boranophosphate backbone: a mimic of phosphodiesters, phosphorothioates, and methyl phosphonates.

B R Shaw1, D Sergueev, K He, K Porter, J Summers, Z Sergueeva, V Rait.   

Abstract

Nucleoside boranophosphates are distinctive in that one of the non-bridging oxygens in the phosphate diester 1 is replaced by a borane moiety (BH3). Although they retain the same net charge, BH3(-)-ODN have unique chemical and biochemical characteristics relative to other analogs. The change in polarity, lipophilicity, nuclease resistance, and the activation of RNase H cleavage of RNA in RNA: boranophosphate hybrids make boranophosphates very attractive for applications in enzymology and molecular biology and as potential antisense agents.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10595359     DOI: 10.1016/s0076-6879(00)13015-0

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  7 in total

1.  Boron-containing aptamers to ATP.

Authors:  Susan M Lato; Nicole D S Ozerova; Kaizhang He; Zinaida Sergueeva; Barbara Ramsay Shaw; Donald H Burke
Journal:  Nucleic Acids Res       Date:  2002-03-15       Impact factor: 16.971

Review 2.  DNA and RNA derivatives to optimize distribution and delivery.

Authors:  Eric Wickstrom
Journal:  Adv Drug Deliv Rev       Date:  2015-04-22       Impact factor: 15.470

3.  Inhibition of hepatitis C viral RNA-dependent RNA polymerase by α-P-boranophosphate nucleotides: exploring a potential strategy for mechanism-based HCV drug design.

Authors:  Marcus Adrian Cheek; Mariam L Sharaf; Mikhail I Dobrikov; Barbara Ramsay Shaw
Journal:  Antiviral Res       Date:  2013-03-04       Impact factor: 5.970

4.  Thymidine analogue resistance suppression by V75I of HIV-1 reverse transcriptase: effects of substituting valine 75 on stavudine excision and discrimination.

Authors:  Tania Matamoros; María Nevot; Miguel Angel Martínez; Luis Menéndez-Arias
Journal:  J Biol Chem       Date:  2009-09-29       Impact factor: 5.157

5.  RNA interference using boranophosphate siRNAs: structure-activity relationships.

Authors:  Allison H S Hall; Jing Wan; Erin E Shaughnessy; Barbara Ramsay Shaw; Kenneth A Alexander
Journal:  Nucleic Acids Res       Date:  2004-11-15       Impact factor: 16.971

Review 6.  Antisense therapy in neurology.

Authors:  Joshua J A Lee; Toshifumi Yokota
Journal:  J Pers Med       Date:  2013-08-02

Review 7.  Engineering the RNA-Nanobio Interface.

Authors:  Vaibhav Murthy; Robert K Delong
Journal:  Bioengineering (Basel)       Date:  2017-02-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.